Strong Revenue Growth
Siemens Healthineers reported a Q3 revenue growth of 7.6% with all regions showing growth, outpacing their full-year growth target. Imaging revenue grew by nearly 12% and Varian saw a 9% growth. Adjusted EPS grew by 23% to EUR 0.64 per share.
Impressive Margins and Financial Performance
Despite a EUR 100 million tariff headwind, Siemens Healthineers achieved margin expansion with Imaging margins at 21% and Varian margins at 18.8%. The company also reported a strong free cash flow, reducing leverage below 3x for the first time since the Varian acquisition.
Innovation and Strategic Partnerships
The Atellica franchise in Diagnostics is growing double digits and accounts for 60% of core lab revenues. Siemens Healthineers' Value Partnerships have grown significantly, reshaping revenue streams into recurring revenue. The company has entered into over 200 Value Partnerships.
Photon Counting CT Success
Photon Counting CT has been a significant growth driver within the CT segment, contributing to high-end CT market share gains globally.